eIF2B is a multisubunit protein that is critical for protein synthesis initiation and its control. It is a guanine nucleotide exchange factor (GEF) for its GTP-binding protein partner eIF2. eIF2 binds initiator tRNA to ribosomes and promotes mRNA AUG codon recognition. eIF2B is critical for regulation of protein synthesis via a conserved mechanism of phosphorylation of eIF2, which converts eIF2 from a substrate to an inhibitor of eIF2B GEF. In addition, inherited mutations affecting eIF2B subunits cause the fatal disorder leukoencephalopathy with Vanishing White Matter (VWM), also called Childhood Ataxia with Central nervous system Hypomyelination (CACH). Here we review findings which reveal that eIF2B is a decameric protein and also define a new function for the eIF2B. Our results demonstrate that the eIF2Bγ subunit is required for eIF2B to gain access to eIF2•GDP. Specifically it displaces a third translation factor eIF5 (a dual function GAP and GDI) from eIF2•GDP/eIF5 complexes. Thus eIF2B is a GDI displacement factor (or GDF) in addition to its role as a GEF, prompting the redrawing of the eIF2 cycling pathway to incorporate the new steps. In structural studies using mass spectrometry and cross-linking it is shown that eIF2B is a dimer of pentamers and so is twice as large as previously thought. A binding site for GTP on eIF2B was also found, raising further questions concerning the mechanism of nucleotide exchange. The implications of these findings for eIF2B function and for VWM/CACH disease are discussed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613454PMC
http://dx.doi.org/10.4161/15384101.2014.948797DOI Listing

Publication Analysis

Top Keywords

eif2b
12
protein synthesis
8
nucleotide exchange
8
protein
6
eif2
5
function
4
function complexity
4
complexity protein
4
protein translation
4
translation initiation
4

Similar Publications

Vanishing white matter (VWM) disease is an autosomal recessive disorder caused by mutations in the gene EIF2B encoding the subunits 1-5 of eukaryotic initiation factor 2B. Although rare, with a reported prevalence of 1:80,000 (0.001%), it was considered as one of the most common leukodystrophies.

View Article and Find Full Text PDF

We report the case of a 76-year-old male patient with systemic sclerosis positive for anti-eukaryotic initiation factor 2B (eIF2B) antibodies. He presented to our hospital with dyspnea on exertion and, following a comprehensive physical examination, was diagnosed with interstitial lung disease associated with systemic sclerosis. Furthermore, systemic sclerosis was positive for the anti-eIF2B antibody.

View Article and Find Full Text PDF

Background: Vanishing white matter syndrome is one of the leukoencephalopathies caused by recessive mutations in gene . Adult-onset EIF2B-pathies (clinical onset after age 16 years) have been reported to be less common.

Objective: Description of the clinical, imaging and genetic profile of adult-onset EIF2B-pathies and comparison of Indian cohort with Asian and European cohorts.

View Article and Find Full Text PDF

Disordered regions of human eIF4B orchestrate a dynamic self-association landscape.

Nat Commun

October 2024

University of Bordeaux, Inserm, CNRS, ARNA Laboratory, U1212, UMR 5320, Institut Européen de Chimie et Biologie, F-33600, Pessac, France.

Article Synopsis
  • Eukaryotic translation initiation factor eIF4B is crucial for effective cap-dependent translation, is commonly overexpressed in cancer cells, and may play a role in stress granule formation.
  • Due to its high intrinsic disorder, eIF4B is often not seen in cryo-EM studies of translation complexes, with most observations limited to its structured RNA recognition motif domain.
  • Research incorporating experiments and simulations reveals that eIF4B's intrinsically disordered region (IDR) helps transition from monomers to larger dynamic oligomers, influenced by factors like ionic strength and molecular crowding, hinting at potential regulatory mechanisms affecting its behavior in cells.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!